Aortic valve stenosis represents the clinically most important valvular heart disease in the elderly patient population. For several decades, surgical aortic valve replacement has been considered the standard in the treatment of symptomatic patients. In the search for less invasive treatment options, transcatheter aortic valve implantation (TAVI) was introduced in 2002 and nowadays represents an alternative treatment option for non-operable or high-risk patients for conventional surgery. The SWISS TAVI Registry is a prospective multi-center, observational study performed in Switzerland and aims to assess prospectively the safety and efficacy in a consecutively enrolled patient cohort undergoing TAVI with CE mark approved devices at Swiss cardiovascular centers.

Herz- und thorak. Gefässchir., Kardiologie

Klinisch

Krankheit / Diagnose, Intervention / Therapie, Risiken / Gesundheitsrelevante Bedingungen, Ergebnis-, Prozess-, Strukturqualität

Aktiv, seit 2011

Patienten mit schwerer, symptomatischer Aortenklappenstenose

Kontinuierlich

National, Alle Schweizer Herzzentren, die TAVI Interventionen durchführen nehmen an dem Register teil

Spitäler, Universitäten

Privat

Universitätsspital Bern, Inselspital, Abteilung für Kardiologie
Freiburgstrasse
3010 Bern